Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
09 03 2021
Historique:
entrez: 2 3 2021
pubmed: 3 3 2021
medline: 17 8 2021
Statut: ppublish

Résumé

Human respiratory syncytial virus (RSV) nonstructural protein 2 (NS2) inhibits host interferon (IFN) responses stimulated by RSV infection by targeting early steps in the IFN-signaling pathway. But the molecular mechanisms related to how NS2 regulates these processes remain incompletely understood. To address this gap, here we solved the X-ray crystal structure of NS2. This structure revealed a unique fold that is distinct from other known viral IFN antagonists, including RSV NS1. We also show that NS2 directly interacts with an inactive conformation of the RIG-I-like receptors (RLRs) RIG-I and MDA5. NS2 binding prevents RLR ubiquitination, a process critical for prolonged activation of downstream signaling. Structural analysis, including by hydrogen-deuterium exchange coupled to mass spectrometry, revealed that the N terminus of NS2 is essential for binding to the RIG-I caspase activation and recruitment domains. N-terminal mutations significantly diminish RIG-I interactions and result in increased IFNβ messenger RNA levels. Collectively, our studies uncover a previously unappreciated regulatory mechanism by which NS2 further modulates host responses and define an approach for targeting host responses.

Identifiants

pubmed: 33649232
pii: 2020587118
doi: 10.1073/pnas.2020587118
pmc: PMC7958447
pii:
doi:

Substances chimiques

NS2 protein, human respiratory syncytial virus 0
RNA, Messenger 0
Receptors, Immunologic 0
Viral Nonstructural Proteins 0
Interferon-beta 77238-31-4
RIGI protein, human EC 3.6.1.-
IFIH1 protein, human EC 3.6.1.-
DEAD Box Protein 58 EC 3.6.4.13
Interferon-Induced Helicase, IFIH1 EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI140758
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI107056
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM103422
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109945
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI120943
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114654
Pays : United States
Organisme : NIGMS NIH HHS
ID : R24 GM136766
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109664
Pays : United States

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Virol. 2005 Jul;79(14):9315-9
pubmed: 15994826
PLoS Pathog. 2008 May 30;4(5):e1000077
pubmed: 18516301
Cell. 2013 Jan 17;152(1-2):276-89
pubmed: 23273991
Immunity. 2013 Mar 21;38(3):437-49
pubmed: 23499489
Nat Rev Microbiol. 2016 Jun;14(6):360-73
pubmed: 27174148
Front Immunol. 2019 Jul 17;10:1586
pubmed: 31379819
Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50
pubmed: 16552146
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5
pubmed: 20057045
J Virol. 2004 Apr;78(8):4363-9
pubmed: 15047850
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W545-9
pubmed: 20457744
J Virol. 2009 Oct;83(19):9682-93
pubmed: 19625398
Science. 2013 Feb 8;339(6120):690-3
pubmed: 23328395
PLoS Pathog. 2010 Jan 22;6(1):e1000734
pubmed: 20107606
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5646-51
pubmed: 24706898
Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):247-55
pubmed: 10089417
Sci Adv. 2019 Oct 02;5(10):eaax3641
pubmed: 31616790
Viruses. 2018 Dec 14;10(12):
pubmed: 30558248
Clin Vaccine Immunol. 2009 Jun;16(6):816-23
pubmed: 19386802
J Pharm Sci. 2011 Jun;100(6):2071-86
pubmed: 21491437
Science. 2010 Jan 15;327(5963):284-6
pubmed: 20075242
J Virol. 2000 Sep;74(18):8234-42
pubmed: 10954520
J Virol. 2008 Jan;82(1):335-45
pubmed: 17942531
Nature. 2007 Apr 19;446(7138):916-920
pubmed: 17392790
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W615-9
pubmed: 15215462
J Virol. 2008 Sep;82(17):8780-96
pubmed: 18562519
Cell. 2011 Oct 14;147(2):409-22
pubmed: 22000018
Mol Biol Rep. 2013 Jan;40(1):675-9
pubmed: 23054021
J Virol. 2006 Jun;80(11):5168-78
pubmed: 16698997
J Virol. 2016 Jun 24;90(14):6453-6463
pubmed: 27147743
Mol Cell. 2005 Sep 16;19(6):727-40
pubmed: 16153868
J Innate Immun. 2014;6(5):650-62
pubmed: 24800889
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):426-36
pubmed: 20382996
Immunity. 2013 May 23;38(5):855-69
pubmed: 23706667
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
pubmed: 17452350
mBio. 2014 Sep 23;5(5):e01704-14
pubmed: 25249281
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13169-74
pubmed: 25157129
Immunol Rev. 2009 Jan;227(1):54-65
pubmed: 19120475
Immunity. 2012 Jun 29;36(6):959-73
pubmed: 22705106
Nat Struct Mol Biol. 2010 Feb;17(2):165-72
pubmed: 20081868
Cell. 2005 Sep 9;122(5):669-82
pubmed: 16125763
J Virol. 2014 Apr;88(8):4572-85
pubmed: 24478431
Biochem Biophys Res Commun. 2016 Sep 23;478(3):1436-41
pubmed: 27569280
J Virol. 2010 Jul;84(14):7267-77
pubmed: 20410276
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
J Virol. 2012 Aug;86(15):8245-58
pubmed: 22623778
J Gen Virol. 2017 Dec;98(12):2912-2913
pubmed: 29087278
Cell. 2019 May 16;177(5):1187-1200.e16
pubmed: 31006531
J Virol. 1999 Apr;73(4):3438-42
pubmed: 10074199
Curr Opin Virol. 2015 Jun;12:91-8
pubmed: 25942693
J Virol. 2007 Feb;81(4):1786-95
pubmed: 17151097
Cell Host Microbe. 2009 May 8;5(5):439-49
pubmed: 19454348
Immunol Rev. 2011 Sep;243(1):91-8
pubmed: 21884169
J Virol. 2009 Apr;83(8):3734-42
pubmed: 19193793
J Virol. 2017 Aug 24;91(18):
pubmed: 28659477
J Biol Chem. 2009 Jun 12;284(24):16202-16209
pubmed: 19380580
PLoS Pathog. 2011 Apr;7(4):e1001336
pubmed: 21533073
Acta Crystallogr D Biol Crystallogr. 2003 Nov;59(Pt 11):2031-8
pubmed: 14573959
Nature. 2011 Sep 25;479(7373):423-7
pubmed: 21947008
J Virol. 2010 Jan;84(1):372-9
pubmed: 19846522
Vaccine. 2003 Sep 8;21(25-26):3647-52
pubmed: 12922094
J Virol. 2005 May;79(9):5353-62
pubmed: 15827150
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):1002-11
pubmed: 16929101
Cell Res. 2013 Aug;23(8):1025-42
pubmed: 23877405
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):425-30
pubmed: 22505262
Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
pubmed: 16855301
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Methods Enzymol. 2003;374:300-21
pubmed: 14696379
Acta Crystallogr A. 2003 May;59(Pt 3):228-34
pubmed: 12714773
Nat Immunol. 2005 Oct;6(10):981-8
pubmed: 16127453
J Virol. 2012 Aug;86(15):7777-89
pubmed: 22593156
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21010-5
pubmed: 22160685
J Virol. 2010 Aug;84(16):8051-61
pubmed: 20519382
J Mol Cell Biol. 2014 Apr;6(2):154-63
pubmed: 24755855
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94
pubmed: 11027311
J Virol. 2011 Oct;85(19):10090-100
pubmed: 21795342
Am J Respir Crit Care Med. 2014 Feb 15;189(4):437-48
pubmed: 24417465
J Virol. 2013 Mar;87(5):2974-8
pubmed: 23269789
J Virol. 2010 Feb;84(4):1785-91
pubmed: 20007272
J Virol. 2007 Feb;81(3):1401-11
pubmed: 17108032
Curr Opin Struct Biol. 2012 Jun;22(3):297-303
pubmed: 22560447
Nature. 2006 May 4;441(7089):101-5
pubmed: 16625202
J Synchrotron Radiat. 2013 Jan;20(Pt 1):37-48
pubmed: 23254654
PLoS One. 2012;7(2):e29386
pubmed: 22383950
Clin Microbiol Rev. 2017 Jan;30(1):277-319
pubmed: 27903593
Cell. 2011 Oct 14;147(2):423-35
pubmed: 22000019
J Virol. 2008 Mar;82(5):2040-55
pubmed: 17928346
J Virol. 1998 Jul;72(7):5707-16
pubmed: 9621029
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):470-8
pubmed: 20383000
J Virol. 2013 Jan;87(2):1242-51
pubmed: 23152520
Nature. 2005 Oct 20;437(7062):1167-72
pubmed: 16177806
Nat Microbiol. 2017 Jun 30;2:17101
pubmed: 28665409
J Immunol. 2008 Apr 1;180(7):4910-8
pubmed: 18354215
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325
J Pharm Sci. 2019 Feb;108(2):807-810
pubmed: 30339865
J Gen Virol. 2011 Sep;92(Pt 9):2153-2159
pubmed: 21632562
J Virol. 2000 Oct;74(19):9317-21
pubmed: 10982380
Virology. 2006 Jan 20;344(2):328-39
pubmed: 16216295

Auteurs

Jingjing Pei (J)

John T. Milliken Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110.

Nicole D Wagner (ND)

Department of Chemistry, Washington University in St. Louis, St. Louis, MO 63110.

Angela J Zou (AJ)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.

Srirupa Chatterjee (S)

John T. Milliken Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110.

Dominika Borek (D)

Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390.

Aidan R Cole (AR)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.

Preston J Kim (PJ)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.

Christopher F Basler (CF)

Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303.

Zbyszek Otwinowski (Z)

Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390.

Michael L Gross (ML)

Department of Chemistry, Washington University in St. Louis, St. Louis, MO 63110.

Gaya K Amarasinghe (GK)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.

Daisy W Leung (DW)

John T. Milliken Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110; dwleung@wustl.edu.
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH